Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

31.600
-0.680-2.11%
Volume:548.80K
Turnover:17.43M
Market Cap:7.81B
PE:253.49
High:32.260
Open:31.540
Low:31.420
Close:32.280
52wk High:56.550
52wk Low:25.250
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:0.96
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.125
ROE:0.57%
ROA:-1.87%
PB:1.40
PE(LYR):253.49
PS:6.45

Loading ...

Hong Kong Stock Movement | CANSINOBIO (06185) Rises Nearly 6% Again; 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine Approved for Clinical Trials

Stock News
·
Jan 07

CanSino Biologics Inc.'s (HKG:6185) last week's 4.5% decline must have disappointed individual investors who have a significant stake

Simply Wall St.
·
Dec 30, 2025

CanSino Biologics Initiates Phase 1 Study of Pediatric Combination Vaccine

MT Newswires Live
·
Dec 22, 2025

CANSINOBIO (06185) Initiates Phase I Clinical Trial for DTcP-Hib-MCV4 Combined Vaccine and Completes First Subject Enrollment

Stock News
·
Dec 19, 2025

Southbound Capital Flow Data (T+2) for Dec 8

Stock News
·
Dec 08, 2025

CanSino Biologics Inc. (06185) Announces November 2025 Monthly Return on Movements in Securities

Bulletin Express
·
Dec 03, 2025

CanSino (6185) Announces Board and Committee Composition

Bulletin Express
·
Nov 27, 2025

CanSino Biologics (6185) Announces EGM Results, Amended Articles, and Board Adjustments

Bulletin Express
·
Nov 27, 2025

CANSINOBIO (06185): Zuo Min and Ji Xuefeng Elected as Independent Non-Executive Directors

Stock News
·
Nov 27, 2025

CanSino Biologics Inc. (688185) Announces Cancellation of Treasury Shares, Issued Shares Total 114,372,901

Bulletin Express
·
Nov 27, 2025

CANSINOBIO (06185) Cancels 406,100 Repurchased Shares

Stock News
·
Nov 27, 2025

CANSINOBIO (06185) to Cancel 406,100 Repurchased A Shares

Stock News
·
Nov 26, 2025

Benign Growth For CanSino Biologics Inc. (HKG:6185) Underpins Its Share Price

Simply Wall St.
·
Nov 20, 2025

CanSino Biologics Begins Phase 1 Trial of Tuberculosis Booster Vaccine in Indonesia

MT Newswires Live
·
Nov 13, 2025

CanSino Biologics (6185) Announces Phase I Clinical Trial Launch and First Patient Enrollment for Inhaled TB Booster in Indonesia

Bulletin Express
·
Nov 13, 2025

CanSino Biologics Inc. (6185) Announces 2025 Second Extraordinary General Meeting Notice

Bulletin Express
·
Nov 11, 2025

CanSino Biologics Inc. (6185) Issues Proxy Form for 2025 Second Extraordinary General Meeting

Bulletin Express
·
Nov 11, 2025

CanSino Biologics (6185) Announces Board of Supervisors Cancellation, Governance Updates, and Director Nominations

Bulletin Express
·
Nov 11, 2025

CanSino Biologics to Use Reserves to Offset Accumulated 1.45 Billion Yuan Losses; Shares Gain 3%

MT Newswires Live
·
Nov 10, 2025

CANSINOBIO (06185) Proposes Using Capital Reserve to Offset Losses

Stock News
·
Nov 07, 2025